1. Abstract
Objectives To systematically review and meta-analyse the genotoxic impact of prenatal and early childhood pesticide exposure, investigating prevalence, specific pesticides, effect size, mechanisms, genetic susceptibility, and vulnerable periods.
Study Design A protocol for systematic review and meta-analysis. A pilot study was also conducted to develop appropriate extraction and risk of bias tool.
Methods Adhering to 2020 PRISMA guidelines, the review will explore genotoxic impact of prenatal and early childhood pesticide exposure in children up to 5 years. The protocol had been registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42024510877). Searches was done across PubMed, EMBASE, Web of Science, and Scopus use keywords ‘prenatal or childhood’, ‘pesticides’, and ‘genotoxicity’. Manual reference screening supplements searches. Eligible observational studies (cross-sectional, case-control, cohort designs) in English will be included, while excluding case reports and in vitro studies, using Covidence screening tool. Two independent reviewers will use Newcastle-Ottawa Scale and novel tool for cross-sectional studies for screening, data extraction, and risk of bias assessment. Findings will be synthesized narratively, with potential meta-analysis of genotoxicity outcomes. GRADE approach will assess the evidence quality.
Results A pilot test screened 1,405 studies, resulting in 21 eligible for full-text screening. Twelve were excluded. Data extraction and risk of bias assessment followed pre-defined protocols. Findings informed the refinement of study procedures.
Conclusions The protocol outlines a comprehensive approach to systematically review the genotoxic impact of prenatal and early childhood pesticide exposure, aiming to provide necessary insights to a better understanding of this environmental risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The contribution of MS was supported by the United Arab Emirates University PhD grant; while the work of AD was supported by the Pathfinder Epidemiology Academy [24PFA04, 2024].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
202190149{at}uaeu.ac.ae (MS);
Ayavet27{at}hotmail.com (AD)
Data Availability
All data produced in the present work are contained in the manuscript.
List of abbreviations
- GRADE
- Grading of Recommendations Assessment, Development and Evaluation
- NOS
- Newcastle-Ottawa Scale
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-analyses.
- PECO
- Population, Exposure, Comparator and Outcomes.
- RoB
- Risk of Bias.
- QoE
- Quality of cumulative Evidence
